Paper42007448
Biological and clinical characteristics of ETV6::RUNX1-like ALL.
Zaliova M and 32 others. Hemasphere, 2026. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. Biological and clinical characteristics of ETV6::RUNX1-like ALL. Papers, record 42007448. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42007448
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References32
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 35985167 | PAX5 fusion genes are frequent in poor risk childhood acute lymphoblastic leukaemia and can be targeted with BIBF1120. | EBioMedicine | 2022 | https://conductscience.org/library/papers/35985167 | PubMed |
| 2 | 18005092 | CD44 and CD27 delineate B-precursor stages with different recombination status and with an uneven distribution in nonmalignant and malignant hematopoiesis. | Tissue Antigens | 2008 | https://conductscience.org/library/papers/18005092 | PubMed |
| 3 | 29498923 | IKZF1plus Defines a New Minimal Residual Disease-Dependent Very-Poor Prognostic Profile in Pediatric B-Cell Precursor Acute Lymphoblastic Leukemia. | J Clin Oncol | 2018 | https://conductscience.org/library/papers/29498923 | PubMed |
| 4 | 36658219 | ETV6 dependency in Ewing sarcoma by antagonism of EWS-FLI1-mediated enhancer activation. | Nat Cell Biol | 2023 | https://conductscience.org/library/papers/36658219 | PubMed |
| 5 | 31821407 | IKZF1 deletions in pediatric acute lymphoblastic leukemia: still a poor prognostic marker? | Blood | 2020 | https://conductscience.org/library/papers/31821407 | PubMed |
| 6 | 28395118 | ETV6/RUNX1-like acute lymphoblastic leukemia: A novel B-cell precursor leukemia subtype associated with the CD27/CD44 immunophenotype. | Genes Chromosomes Cancer | 2017 | https://conductscience.org/library/papers/28395118 | PubMed |
| 7 | 22441210 | Outcome in children with Down's syndrome and acute lymphoblastic leukemia: role of IKZF1 deletions and CRLF2 aberrations. | Leukemia | 2012 | https://conductscience.org/library/papers/22441210 | PubMed |
| 8 | 34250504 | Clinical significance of novel subtypes of acute lymphoblastic leukemia in the context of minimal residual disease-directed therapy. | Blood Cancer Discov | 2021 | https://conductscience.org/library/papers/34250504 | PubMed |
| 9 | 19838194 | Rearrangement of CRLF2 in B-progenitor- and Down syndrome-associated acute lymphoblastic leukemia. | Nat Genet | 2009 | https://conductscience.org/library/papers/19838194 | PubMed |
| 10 | 27269950 | Successful Therapy Reduction and Intensification for Childhood Acute Lymphoblastic Leukemia Based on Minimal Residual Disease Monitoring: Study ALL10 From the Dutch Childhood Oncology Group. | J Clin Oncol | 2016 | https://conductscience.org/library/papers/27269950 | PubMed |
| 11 | 31765480 | Results of CoALL 07-03 study childhood ALL based on combined risk assessment by in vivo and in vitro pharmacosensitivity. | Blood Adv | 2019 | https://conductscience.org/library/papers/31765480 | PubMed |
| 12 | 30643249 | PAX5-driven subtypes of B-progenitor acute lymphoblastic leukemia. | Nat Genet | 2019 | https://conductscience.org/library/papers/30643249 | PubMed |
| 13 | 37001051 | Genomic landscape of Down syndrome-associated acute lymphoblastic leukemia. | Blood | 2023 | https://conductscience.org/library/papers/37001051 | PubMed |
| 14 | 20139093 | Rearrangement of CRLF2 is associated with mutation of JAK kinases, alteration of IKZF1, Hispanic/Latino ethnicity, and a poor outcome in pediatric B-progenitor acute lymphoblastic leukemia. | Blood | 2010 | https://conductscience.org/library/papers/20139093 | PubMed |
| 15 | 26888258 | Dexamethasone vs prednisone in induction treatment of pediatric ALL: results of the randomized trial AIEOP-BFM ALL 2000. | Blood | 2016 | https://conductscience.org/library/papers/26888258 | PubMed |
| 16 | 25207766 | Targetable kinase-activating lesions in Ph-like acute lymphoblastic leukemia. | N Engl J Med | 2014 | https://conductscience.org/library/papers/25207766 | PubMed |
| 17 | 24222333 | Acute lymphoblastic leukemia in children with Down syndrome: a retrospective analysis from the Ponte di Legno study group. | Blood | 2014 | https://conductscience.org/library/papers/24222333 | PubMed |
| 18 | 36658220 | The ETS transcription factor ETV6 constrains the transcriptional activity of EWS-FLI to promote Ewing sarcoma. | Nat Cell Biol | 2023 | https://conductscience.org/library/papers/36658220 | PubMed |
| 19 | 21414819 | Identification of characteristic IGF2BP expression patterns in distinct B-ALL entities. | Blood Cells Mol Dis | 2011 | https://conductscience.org/library/papers/21414819 | PubMed |
| 20 | 36550215 | Integrative genomic analysis of childhood acute lymphoblastic leukaemia lacking a genetic biomarker in the UKALL2003 clinical trial. | Leukemia | 2023 | https://conductscience.org/library/papers/36550215 | PubMed |
Genes5
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CD27 | 939 | PubTator's text mining | https://conductscience.org/library/genes/939 | NCBI Gene |
| CRLF2 | 64109 | PubTator's text mining | https://conductscience.org/library/genes/64109 | NCBI Gene |
| ETV6 | 2120 | PubTator's text mining | https://conductscience.org/library/genes/2120 | NCBI Gene |
| IKZF1 | 10320 | PubTator's text mining | https://conductscience.org/library/genes/10320 | NCBI Gene |
| JAK2 | 3717 | PubTator's text mining | https://conductscience.org/library/genes/3717 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/42007448
GET https://conductscience.org/api/papers/v1/42007448/authors?page=2